Institute for Research in Biomedicine

Protein Folding and Quality Control

The endoplasmic reticulum (ER) contains high concentrations of molecular chaperones and enzymes that assist maturation of newly synthesized polypeptides destined to the extracellular space, the plasma membrane and the organelles of the endocytic and secretory pathways. It also contains quality control factors that select folding-defective proteins for ER retention and/or ER-associated degradation (ERAD). Mutations, deletions and truncations in the polypeptide sequences may cause protein-misfolding diseases characterized by a “loss-of-function” upon degradation of the mutant protein or by a “gain-of-toxic-function” upon its aggregation/deposition. Pathogens hijack the machineries regulating protein biogenesis, quality control and transport for host invasion, genome replication and progeny production. Our long-standing interest is to understand the molecular mechanisms regulating chaperone-assisted protein folding and the quality control processes determining whether a polypeptide can be secreted, should be retained in the ER, or should be selected for degradation. More recently, particular emphasis has been given to the characterization of transcriptional and post translational responses activated by cells experiencing ER stresses, to the mechanisms ensuring clearance of polymeric and aggregated proteins from the ER and to the study of select rare diseases such as α1-antitrypsin deficiency, lysosomal storage diseases and Charcot-Marie-Tooth 1B neuropathy. A thorough knowledge of the processes ensuring protein biogenesis and maintenance of cellular proteostasis will be instrumental to identify drug targets and/or to design therapies for diseases caused by inefficient functioning of the cellular protein factory, resulting from expression of defective gene products (e.g. rare genetic disorders), or elicited by pathogens.

Projects

Group leader: Maurizio Molinari
Researchers: Timothy Jan Bergmann – Research Assistant, Ilaria Fregno  -Research Assistant, Carmela Galli Molinari – Scientist
Status: In progress

The equilibrium between protein synthesis, export and ERAD is crucial for maintaining ER homeostasis. Different physiological and pathological conditions (e.g. fluctuations in protein synthesis, accumulation of defective gene products, pathogens…) can perturb the ER environment, leading to conditions of ER-stress. Such stresses can lead to the activation of the UPR, adaptive, transcriptional and translational programs that induce the expression of ER resident gene products, increase the ER size and reduce synthesis of cargo protein in order to restore ER homeostasis. The aim of this project is to investigate how cells respond to perturbations of the ER environment upon tunable expression of a selection of model proteins with different physico-chemical features or upon exposure to ER-stress inducing drugs. Experimental data from the lab show that cells respond differently to increasing amount of misfolded ER proteins. While some proteins do not induce an UPR even at high molar concentrations (Figure 1A-1B, 1E), other proteins elicit UPR already at low dosage (Figure 1C-1E). Thus, the threshold for activation of transcriptional programs in response to increasing burden of misfolded protein (Figure 2) must depend on intrinsic features of the accumulating polypeptide. We will couple genome wide gene expression profiling (in collaboration with F. Bertoni, IOR, Bellinzona) with proteome analysis, shotgun and selected reaction monitoring-based (SRM) proteomics (in collaboration with P. Picotti, ETH Zurich) in order to establish transcriptional and post-translational cellular response “fingerprints” associated to individual defective polypeptide expression and drug treatments. Responses to accumulation of misfolded proteins below the threshold required for UPR activation will be analyzed with particular care. These responses that we collectively termed ERAD tuning could rely on post-translational mechanisms, which have much shorter latency, since they do not depend on gene transcription and translation (e.g. modulation of ER-resident proteins turnover, formation/disassembly of functional complexes, sub-compartmental de-localization, post-translational modifications such as ADP-ribosylation, palmitoylation, …). Some of these non-transcriptional responses that regulate ER-resident proteins level and activity are hijacked by human pathogens during their infection cycle.

Figure 1: Substrate-dependent ER stress-induction. (A) Tet-induced expression of CD3δ-HA. BiP, GRP94 and HERP levels. Last lane, Tun-induced ER stress (5µg/ml). (B) Variations of CD3δ (fmol protein/ cell) and BiP transcripts. (C)-(D) same as (A)-(B) for BACE457. (E) Induction of stress markers at maximal CD3δ and BACE457 doses and at 5µg/ml Tun, quantitative real time PCR.

Figure 2: Induction of non-transcriptional and transcriptional UPR. Threshold (dotted line) shows the level of model protein that triggers a transcriptional UPR (UPRTr). Below the threshold, responses, if any, are not-transcriptional, and ill-defined.

Noack et al., J Virol. 2014; 88:10272-10275.

Noack et al., Nat Chem Biol. 2014; 10:881-882.

Noack et al.,Swiss Med Wkly. 2014; 144:w14001.

up